Looking for a taste of what to expect from Certainty by Certara? We’re happy to share a sample of our recorded main stage sessions from the 2026 event in Boston, MA. These insightful, expert-packed presentations paired with robust, product-specific breakout tracks make Certainty an unmissable event. Be the first to hear when registration for our 2027 events open – join the waitlist.
Get an exclusive look at the inspiring presentation from our 2026 Certainty US Keynote, Dr. David Fajgenbaum, who shared his story of seeking and developing novel treatment for Castleman disease. Dr. Fajgenbum is the Co-founder and President of Every Cure, bestselling author of “Chasing My Cure”, and a physician-scientist at the University of Pennsylvania.
Leaders in PBPK and QSP discuss critical regulatory shifts shaping MIDD and the evolution to Model-Informed Evidence (MIE). The conversation also explores the most effective applications of AI in drug development and where its influence is unlikely to extend within scientific processes.
This session highlighted Merck’s approach to integrating Certara solutions & scientific expertise to improve decision-making at every phase of drug development. The discussion also examined how AI is solving fragmented workflows and how this leads to exponential growth in productivity.
This panel of industry experts discussed how to operationalize innovative technology & science for faster, better decision-making. Panelists also shared where they expect strategy and processes to evolve in the future.